Full Name
Eng King Tan
Variants
Tan, E.-K.
Tan, E.K.
 
 
 
Email
gmstek@nus.edu.sg
 

Refined By:
Department:  BIOLOGY (NU)
Author:  Zhou Z.-D.
Department:  DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)

Results 1-17 of 17 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
12015Association analysis of COQ2 variant in dementia and essential tremorChao Y.X. ; Ng E.Y.L.; Li H. ; Nagaendran K. ; Yih Y. ; Chong M.S.; Prakash K.M. ; Tan L. ; Au W.L. ; Zhao Y.; Zhou Z.D. ; Tio M.; Pavanni R. ; Tan E.K. 
22-Dec-2016Dopamine (DA) Dependent Toxicity Relevant to DA Neuron Degeneration in Parkinson’s Disease (PD)Zhou, Zhidong ; Thevapriya, Selvaratnam; Chao, Yin Xia; Lim, Tit Meng ; Tan, Eng King 
316-Oct-2017Dopamine (DA) toxicity in pathogenesis and therapy of Parkinson’s disease (PD)Zhou, Zhidong ; Tan, Eng King 
419-Apr-2022Editorial: The Role of Neurovascular Unit in NeurodegenerationZhou, Zhidong ; Wang, Dennis Qing; Tan, Eng-King 
52017Erratum to: Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases (Molecular Neurobiology, (2017), 54, 7, (5534-5546), 10.1007/s12035-016-0099-5)Zhou Z.-D. ; Saw W.-T.; Tan E.-K. 
62017Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's DiseaseQiu L. ; Liao M.-C.; Chen A.K.; Wei S.; Xie S. ; Reuveny S.; Zhou Z.D. ; Hunziker W. ; Tan E.K. ; Oh S.K.W. ; Zeng L. 
72017Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseasesZhou Z.D. ; Tan E.-K. 
815-Dec-2010Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: Implications for iron-related dopaminergic neuron degenerationZhou, Z.D. ; Lan, Y.H.; Tan, E.K. ; Lim, T.M. 
92017LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stressChen Z. ; Cao Z.; Zhang W.; Gu M. ; Zhou Z.D. ; Li B.; Li J.; Tan E.K. ; Zeng L. 
102017Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative DiseasesZhou Z.-D. ; Saw W.-T.; Tan E.-K. 
11Mar-2014Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neuronsZhou, Zhidong ; Refai, Fathima Shaffra; Xie, Shao Ping; Ng, Shin Hui; Chan, Christine Hui Shan; Ho, Patrick Ghim Hoe; Zhang, Xiao Dong; Lim, Tit Meng ; Tan, Eng King 
121-Mar-2022Neurodegenerative diseases associated with non-coding CGG tandem repeat expansionsZhou, Zhidong ; Jankovic, J; Ashizawa, T; Tan, Eng King 
132017Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's diseaseChen Z.-C. ; Zhang W.; Chua L.-L. ; Chai C. ; Li R.; Lin L.; Cao Z.; Angeles D.C. ; Stanton L.W. ; Peng J.-H.; Zhou Z.-D. ; Lim K.-L. ; Zeng L. ; Tan E.-K. 
142016Plasma coenzyme Q10 levels and multiple system atrophyChao Y.X. ; Zhou Z. ; Tan E.-K. 
1528-Mar-2017Potential Implications of Mitochondrial Unfolded Protein Response in the Pathogenesis and Therapy of Dopaminergic Neuron Degeneration in Parkinson’s Disease.Zhou, Zhidong ; Chao, Yin Xia; Tan, Eng King 
1616-Aug-2019The Therapeutic Implications of Tea Polyphenols against Dopamine (DA) Neuron Degeneration in Parkinson's Disease (PD)Zhou, Zhidong ; Xie, Shao Ping; Saw, Wuan Ting; Ho, Patrick Ghim Hoe; Wang, Hong Yan; Zhou, Lei ; Zhao, Yi; Tan, Eng King 
172017Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variantsTio M. ; Wen R.; Lim Y.L.; Zukifli Z.H.B.; Xie S. ; Ho P.; Zhou Z. ; Koh T.-W. ; Zhao Y.; Tan E.-K.